Concerning the hormonal context, 78.2% of meningiomas developed in a pre-menopausal context expressed progesterone receptors (95% CI: 61.9–94.5) vs. 68.4% of meningiomas developed in a post-menopausal context (95% CI: 62.6–74.2). This evidence concerns the gene PGR and meningioma.